Cargando…
Tumor residue in patients with stage II–IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein–Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose
BACKGROUND: To develop and validate a predictive nomogram for tumor residue 3–6 months after treatment based on postradiotherapy plasma Epstein–Barr virus (EBV) deoxyribonucleic acid (DNA), clinical stage, and radiotherapy (RT) dose in patients with stage II–IVA nasopharyngeal carcinoma (NPC) treate...
Autores principales: | Huang, Ying-Ying, Zhou, Jia-Yu, Zhan, Ze-Jiang, Ke, Liang-Ru, Xia, Wei-Xiong, Cao, Xun, Cai, Zhuo-Chen, Deng, Ying, Chen, Xi, Zhang, Lu-Lu, Huang, Hao-Yang, Guo, Xiang, Lv, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164328/ https://www.ncbi.nlm.nih.gov/pubmed/37149594 http://dx.doi.org/10.1186/s12885-023-10827-0 |
Ejemplares similares
-
Elevated plasma fibrinogen level shows superior prognostic value than Epstein–Barr virus DNA load for stage IVA/B nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era
por: Lan, Mei, et al.
Publicado: (2016) -
A Nomogram for the Determination of the Necessity of Concurrent Chemotherapy in Patients With Stage II–IVa Nasopharyngeal Carcinoma
por: Yang, Kaixuan, et al.
Publicado: (2021) -
Can Epstein–Barr virus‐deoxyribonucleic acid load after induction chemotherapy combined with American Joint Committee on Cancer stage determine the chemotherapy intensity of locally advanced nasopharyngeal carcinoma?
por: Zhang, Qun, et al.
Publicado: (2022) -
Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I–III Pulmonary Lymphoepithelioma-Like Carcinoma
por: Li, Qi-Wen, et al.
Publicado: (2020) -
Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status
por: Peng, Hao, et al.
Publicado: (2016)